Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal

Schizophrenia Bulletin
T M ShiovitzN R Cutler

Abstract

Following the conduct of a 28-day inpatient bioequivalence study of clozapine in schizophrenia patients, withdrawal effects after abrupt discontinuation from clozapine were assessed. Thirty patients who met DSM-III-R criteria for schizophrenia, residual type, or schizophrenia in remission were enrolled in the study. Patients were evaluated for symptoms of withdrawal effects for 7 days after clozapine 200 mg/day was abruptly withdrawn. Of 28 patients who completed the study, 11 had no withdrawal symptoms; 12 had mild withdrawal adverse events of agitation, headache, or nausea; four patients experienced moderate withdrawal adverse events of nausea, vomiting, or diarrhea; and one patient experienced a rapid-onset psychotic episode requiring hospitalization. Cholinergic rebound is a likely explanation for the mild to moderate withdrawal symptoms and is easily treated with an anticholinergic agent. Mesolimbic supersensitivity, as well as specific properties of clozapine, are discussed as likely causes for rapidonset psychosis. Our findings are consistent with previous reports of withdrawal reactions associated with clozapine, further reminding clinicians to monitor patients closely following abrupt discontinuation of clozapine.

Citations

Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Theresa A ZesiewiczRobert A Hauser
Mar 23, 2005·Der Nervenarzt·M Zink, H Dressing
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frank P BymasterDavid L Mckinzie
Aug 17, 1999·European Journal of Pharmacology·M L Wadenberg, P Seeman
Mar 26, 2002·Clinical Therapeutics·Andrew J CutlerJohn A Tumas
Feb 19, 1998·Schizophrenia Research·J L WaddingtonE O'Callaghan
Aug 7, 1999·Journal of Clinical Pharmacy and Therapeutics·N Delassus-GuenaultH Robert
Dec 17, 2004·Clinical Neuropharmacology·Andrew Wei-Chiang YehWei-Hsi Chen
Sep 26, 2002·Psychosomatics·Shishuka MalhotraRukhsana Iqbal
Jan 8, 2003·Psychosomatics·Oliver Freudenreich, Theodore A Stern
Jan 7, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·B GrassiS Scarone
Jul 1, 2010·Expert Review of Clinical Pharmacology·Clare V BostockArduino A Mangoni
Mar 22, 2006·Expert Opinion on Investigational Drugs·Kelvin L Chou, Hubert H Fernandez
May 4, 2011·Acta Psychiatrica Scandinavica·J NielsenD Taylor
Jul 28, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kazuhiko MoriShigeto Yamawaki
Nov 1, 2005·International Journal of Obstetric Anesthesia·J DohertyD J King
Feb 5, 2011·Journal of Psychopharmacology·Thomas R E Barnes, UNKNOWN Schizophrenia Consensus Group of British Association for Psychopharmacology
Jan 12, 2008·Journal of Psychopharmacology·Alaattin DuranMurat Emul
Jun 26, 2017·Psychotherapy and Psychosomatics·Guy ChouinardMasaomi Iyo
Nov 4, 2011·Journal of Pharmacy Practice·James J GuggerCandace Smith
Jan 2, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·William V BoboRichard C Shelton
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M Zaudig
Jun 24, 2017·The Psychiatric Quarterly·Kathleen PatchanDeanna L Kelly
Feb 24, 2001·The Annals of Pharmacotherapy·S Zerjav-Lacombe, V Dewan
Jan 14, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Hanne Indermo SolhaugOlav Kristiansen
Jan 11, 2013·Clinical Schizophrenia & Related Psychoses·Michele Hill, Oliver Freudenreich
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·F KapsaliC Papageorgiou
Nov 3, 2020·Frontiers in Psychiatry·Lasse BrandtStefan Gutwinski
Mar 24, 2021·Schizophrenia Bulletin·Mark Abie HorowitzDavid Taylor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here